
-
India checks Maoist rebel offer of suspending armed struggle
-
Israel to open new route for Gazans fleeing besieged city
-
Lower shipments to US, China weigh on Singapore August exports
-
Inside the hunt for the suspect in Charlie Kirk's killing
-
Junta accused of coveting power in crucial Guinea referendum
-
TV writer Hagai Levi: boycott risks hitting Israel's critical voices
-
Sri Lanka to ban predatory pet fish to protect ecosystems
-
'Genius' De Bruyne leads Napoli in emotional return to Man City
-
World number one Sabalenka out of China Open with injury
-
Estimated 16,500 climate change deaths during Europe summer: study
-
'Fifa' successor 'FC 26' polishes the beautiful game
-
Park Chan-wook's murder comedy to open Asia's biggest film festival
-
India's gaming fans eye illegal sites after gambling ban
-
EU business lobby head says China rare earths snag persists
-
Botox under burqas: Cosmetic surgery in vogue in Afghanistan
-
Asian stocks swing as traders bide time ahead of US rate decision
-
Australia, Papua New Guinea delay mutual defence treaty
-
PGA's 2026 opener will not be played at drought-hit Kapalua
-
Toucans, tortoises saved in major Brazil trafficking bust
-
Britain rolls out royal red carpet for Trump's state visit
-
US Fed set for first rate cut of 2025 as Trump pressure looms
-
Broadway jeering Caesars Times Square casino bet
-
Rojas, McLaughlin-Levrone go for gold at world champs
-
Colombian FARC leaders ordered to make reparations for over 21,000 kidnappings
-
Nano One and Sumitomo Metal Mining Advance Collaboration on LFP Commercialization
-
Hemogenyx Pharmaceuticals PLC Announces Third Patient Safety
-
Alset AI Announces Voluntary Shareholder Lock-Ups Reflecting Confidence in Company's Long-Term Vision
-
Empire Metals Limited Announces Appointment of Marketing Manager
-
Dermata Therapeutics Announces Presentation of Abstract at the European Academy of Dermatology and Venereology Congress 2025
-
Announcing the 2025 Barrie Consumer Choice Award Winners
-
Liberty Personal Loans Support Australians Upgrading Their Homes
-
Kirk suspect faces death penalty for aggravated murder charge
-
Peru evacuates 1,400 tourists from Machu Picchu amid protest
-
Trump arrives in UK for historic second state visit
-
Arsenal, Real Madrid win Champions League openers, Juve snatch dramatic draw
-
Friends like these: NY to get 'Central Perk' cafe from beloved sitcom
-
Mbappe penalty double gives Real Madrid opening win over Marseille
-
Windsor poised for global spotlight with Trump state visit
-
Juve salvage point against Dortmund with stunning late comeback
-
Redford's Sundance legacy hailed by filmmakers
-
Spurs accept Villarreal gift to make winning start in Champions League
-
Trump arrives in Britain for unprecedented second state visit
-
FBI chief spars with Democrats in heated Senate hearing
-
'A better future is possible': Youths sue Trump over climate change
-
Redford's Sundance legacy 'beyond comprehension' for US filmmakers
-
Vuelta protests 'a completely new phenomenon', says Tour de France director
-
Bangladesh beat Afghanistan to stay alive in Asia Cup
-
Trump extends delay on US TikTok ban until mid-December
-
YouTube ramps up AI tools for video makers
-
Arsenal subs snatch win in Bilbao Champions League opener
CMSC | 0.29% | 24.39 | $ | |
NGG | -1.04% | 70.88 | $ | |
JRI | -1.01% | 13.92 | $ | |
CMSD | 0.04% | 24.46 | $ | |
BCE | -1.11% | 23.43 | $ | |
RBGPF | 0% | 77.27 | $ | |
RIO | -0.44% | 63.44 | $ | |
BCC | -3.31% | 82.39 | $ | |
SCS | 0.06% | 16.88 | $ | |
RYCEF | -0.06% | 15.64 | $ | |
GSK | -0.62% | 40.05 | $ | |
AZN | -0.63% | 77.56 | $ | |
BTI | -0.43% | 55.79 | $ | |
VOD | -0.34% | 11.77 | $ | |
RELX | -0.36% | 46.69 | $ | |
BP | 0.64% | 34.43 | $ |

Warmer noses are better at fighting colds: study
Chilly weather and common respiratory infections often go hand in hand.
Reasons for this include people gather inside more in winter, and viruses survive better in low-humidity indoor air. But there has been less certainty about whether lower temperatures actually impair human immunity and, if so, how.
Now, a new study published Tuesday in The Journal of Allergy and Clinical Immunology details a previously unknown way that the immune system attacks viral intruders inside the nose -- and finds it works better when it's warm.
These discoveries could pave the way for an eventual treatment against the common cold and other viruses, Mansoor Amiji, a pharmaceutical sciences professor at Northeastern University, who co-led the research, told AFP.
The starting point was previous research by Amiji and colleagues in 2018, which found that nasal cells released "extracellular vesicles" (EVs) —- a spray of tiny sacs that swarmed and destroyed bacteria upon inhalation.
"The best analogy that we have is a hornet's nest," said Amiji. Like hornets defending a nest from attack, EVs swarm, bind to, and kill invaders.
For the new research, the team set out to answer two questions: are EVs also secreted in the nose in the presence of viral infections? And, if they are, is the strength of their response linked to temperature?
To answer the first question, they used a test substance which mimics a viral infection to stimulate nasal mucosa -- a thin tissue that lines the nose -- that was taken from volunteers who had surgery to remove polyps.
They found it did in fact produce EVs that target viruses.
In order to tackle the second question, they divided the nasal cell samples into two groups and cultured them in a lab, subjecting one set of samples to 37 degrees Celsius, and the other to 32C.
These temperatures were chosen based on a separate test that found the temperature inside the nose falls by about 5C when outside air drops from 23C to 4C.
Under regular body heat conditions, the EVs were successfully able to fight off viruses, by presenting them with "decoy" targets that they latch on to instead of the receptors they would otherwise target on cells.
But under the reduced temperatures, fewer EVs were produced, and those that were made packed less punch against the invaders tested: two rhinoviruses and a non-Covid coronavirus, which are typically found in winter cold season.
"There's never been a convincing reason why you have this very clear increase in viral infectivity in the cold months," said co-author Benjamin Bleier, a surgeon at Harvard Medical School and Massachusetts Eye and Ear, in a statement.
"This is the first quantitative and biologically plausible explanation that has been developed."
One of the most exciting aspects of the work is the potential to rev up the body's natural production of virus-targeting EVs in order to fight or even fend off the cold -- or even the flu and Covid, said Amiji.
"That's an area of great interest for us and we certainly continue to pursue that," he said.
D.Cunningha--AMWN